Your Search for 'Cancer: From Mechanisms to Therapeutic Approaches' returned 83 results - Page 1 of 5

• Drug Delivery in Cancer - Technologies, Markets and Companies

  EURO€ 3,075.00USD$ 4,000.00GBP£ 2,587.00AUD$ 3,912.00JPY¥ 394,932.00SEK 26 263,00CHF 3'770.00CAD$ 4,076.00 Jain PharmaBiotech, May 2013 , Pages: 669
  . The focus is on targeted cancer therapy. The newer approaches to cancer treatment not only supplement the conventional chemotherapy and radiotherapy but also prevent damage to normal tissues and prevent ...

• Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2012 Market Report

  EURO€ 1,250.00USD$ 1,626.00GBP£ 1,052.00AUD$ 1,591.00JPY¥ 160,561.00SEK 10 677,00CHF 1'533.00CAD$ 1,657.00 Select Biosciences Ltd, Jan 2012 , Pages: 122
  Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2012 Market Report This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells ...

• RNAi - Technologies, Markets and Companies

  EURO€ 3,075.00USD$ 4,000.00GBP£ 2,587.00AUD$ 3,912.00JPY¥ 394,932.00SEK 26 263,00CHF 3'770.00CAD$ 4,076.00 Jain PharmaBiotech, May 2013 , Pages: 498
  small molecule inhibitors cannot be found. Areas of therapeutic applications include virus infections, cancer, genetic disorders and neurological diseases. Research at academic centers that is relevant to ...

• Nitric Oxide - Therapeutics, Markets and Companies

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 Jain PharmaBiotech, May 2013 , Pages: 276
  nitric oxide synthase (NOS), which converts L-arginine to NO. NOS can be stimulated as well as inhibited by pharmacological and gene therapy approaches. Important therapeutic areas for NO-based therapies ...

• Gene Therapy - Technologies, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 665
  such as RNA interference (RNAi), further increasing the therapeutic applications. This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic ...

• Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success

  EURO€ 2,400.00USD$ 2,712.00GBP£ 1,600.00AUD$ 3,750.00JPY¥ 325,203.00SEK 21 333,00CHF 3'571.00CAD$ 3,478.00 Spectra Intelligence, Nov 2006 , Pages: 367
  from ‘bench to bedside’ is not only fast-paced but also exciting. There are many new approaches and novel technologies applied to the development of new cancer treatments. The plethora of investigational ...

• US Cancer Pain Report

  EURO€ 7,648.00USD$ 9,950.00GBP£ 6,435.00AUD$ 9,732.00JPY¥ 982,393.00SEK 65 330,00CHF 9'378.00CAD$ 10,139.00 WWMR, Feb 2009 , Pages: 101
  to severe pain from one or more of the following types of cancer pain: - Tumor-related pain; - Treatment-related pain; - Soft-tissue pain; - Visceral pain; - Neuropathic pain; - Bone pain; and ...

• Cell Therapy - Technologies, Markets and Companies

  EURO€ 4,228.00USD$ 5,500.00GBP£ 3,557.00AUD$ 5,379.00JPY¥ 543,031.00SEK 36 112,00CHF 5'184.00CAD$ 5,604.00 Jain PharmaBiotech, May 2013 , Pages: 1050
  delivery of cell therapy range from injections to surgical implantation using special devices. Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous ...

• European Bladder Cancer Therapeutics Markets

  EURO€ 4,996.00USD$ 6,500.00GBP£ 4,203.00AUD$ 6,357.00JPY¥ 641,764.00SEK 42 678,00CHF 6'126.00CAD$ 6,623.00 Frost & Sullivan, Aug 2007 , Pages: 94
  Standard of Care ---4. Current Therapeutic Options - Superficial Bladder Cancer ---5. Current Therapeutic Options - Invasive Bladder Cancer ---6. Future Therapeutic Approaches ---7. Current Treatment ...

• Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Jul 2010 , Pages: 261
  drug developers around the world are using this approach to address everything from allergies to literally every kind of cancer. More than 70 new proprietary technologies are named and explained, with ...

• Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities

  EURO€ 3,622.00USD$ 4,093.00GBP£ 2,415.00AUD$ 5,660.00JPY¥ 490,854.00SEK 32 200,00CHF 5'391.00CAD$ 5,250.00 Spectra Intelligence, Apr 2006 , Pages: 369
  need to identify those chemotherapy approaches that may have the greatest potential for therapeutic success and suggests that there is a need to distinguish important new entries to the cancer ...

• Pain Therapeutics - Drugs, Markets and Companies

  EURO€ 3,075.00USD$ 4,000.00GBP£ 2,587.00AUD$ 3,912.00JPY¥ 394,932.00SEK 26 263,00CHF 3'770.00CAD$ 4,076.00 Jain PharmaBiotech, May 2013 , Pages: 544
  . Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for ...

• Proteomics - Technologies, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 631
  complimentary to genomic approaches. Toxicoproteomics, i.e. the evaluation of protein expression for understanding of toxic events, is an important application of proteomics in preclincial drug safety. Use of ...

• Innovations in Protein Kinase Therapies: Company Pipelines, Therapeutic Applications and Market Forecasts

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, May 2009 , Pages: 335
  of the strategies currently under development for the efficient discovery and optimization of new inhibitors. - Identify the most promising approaches to kinase modulation in cancer and other ...

• Bone Cancer. Progression and Therapeutic Approaches

  EURO€ 103.00USD$ 134.00GBP£ 87.00AUD$ 131.00JPY¥ 13,230.00SEK 880,00CHF 126.00CAD$ 137.00 Elsevier Science and Technology, Oct 2009 , Pages: 504
  which combine surgery and biological therapeutic approaches. Bone is a common site of cancer metastases - cancer cells commonly develop in bone and spread to other organ systems through the bloodstream ...

• Next-Generation Protein and Peptide Therapeutics

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Aug 2011 , Pages: 192
  Bispecific antibodies Therapeutic applications of monoclonal antibodies Drawbacks of mAbs as therapeutics General challenges Obstacles specific to cancer therapy Novel targeted protein therapeutics ...

• Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

  EURO€ 1,123.00USD$ 1,461.00GBP£ 945.00AUD$ 1,429.00JPY¥ 144,277.00SEK 9 595,00CHF 1'377.00CAD$ 1,489.00 PharmaVision, Jul 2009 , Pages: 225
  opinions & market projections to: - assess the commercial potential of RNAi-based therapies in all of the key therapeutic areas: cancer, CNS disorders, viral infectious diseases, ocular diseases ...

• Antiviral Therapeutics - Technologies, Markets and Companies

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 Jain PharmaBiotech, May 2013 , Pages: 501
  Therapeutic approaches to SARS MAbs for SARS siRNA treatment of SARS Human coronavirus-Erasmus Medical Center Zoonotic viral infections Vaccines for zoonotic viral diseases Virus bioterrorism and ...

• Immunotherapy in Oncology: Gaining Momentum

  EURO€ 1,475.00USD$ 1,919.00GBP£ 1,241.00AUD$ 1,877.00JPY¥ 189,462.00SEK 12 599,00CHF 1'809.00CAD$ 1,955.00 Bioseeker, Aug 2006 , Pages: 228
  eradication of tumors, metastatic spread or not. Main strategies of cancer immunotherapy aim at exploiting the therapeutic potential of tumor-specific antibodies and cellular immune effector mechanisms ...

• Intelligent Drug-Delivery Platforms

  EURO€ 400.00USD$ 520.00GBP£ 337.00AUD$ 509.00JPY¥ 51,379.00SEK 3 417,00CHF 490.00CAD$ 530.00 Future Science Ltd, Dec 2012 , Pages: 124
  , Singapore) and Dr Kit S Lam (University of California Davis, CA, USA). The special focus issue offers a look at the present approaches to drug delivery that employ novel designs, mechanisms or applications ...